NCT01593527 Canakinumab in the Treatment of Gouty Arthritis Flare(s) and Prevention of New Flares in Patients With Chronic Kidney Disease Status WITHDRAWN Phase PHASE3
NCT01592097 Exploratory Study to Assess Clinical Response to Gilenya® (Fingolimod) in Hispanics With RRMS Status COMPLETED Phase N/A
NCT01590199 Evaluate Safety and Tolerability of Pasireotide LAR in Combination With Everolimus in Advanced Metastatic NETs Status COMPLETED Phase PHASE1
NCT01589237 Extension to a Randomized, Double-blind, Placebo Controlled Study of LCQ908 in Subjects With Familial Chylomicronemia Syndrome. Status TERMINATED Phase PHASE3
NCT01585298 STudy to vAlidate telemetRic ECG Systems for firsT Dose Administration of Fingolimod (START) Status COMPLETED Phase PHASE4
NCT01585272 Tolerability of Rivastigmine Before and After Switching From Oral Formulation to Transdermal Patch in Alzheimer's Dementia Status COMPLETED Phase PHASE4
NCT01584648 A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma Status COMPLETED Phase PHASE3
NCT01583257 Pilot Study: Active Video Gaming to Facilitate Physical Activity and Quality of Life in Kidney Transplant Recipients Status COMPLETED Phase PHASE1/PHASE2
NCT01582243 Safety and Efficacy of Vildagliptin Plus Metformin (SPC) Treatment in Type 2 Diabetes Mellitus Patients Status COMPLETED Phase PHASE4
NCT01582230 Efficacy and Safety of Vildagliptin 50mg Bid as an add-on Therapy to Insulin With or Without Metformin, in Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT01582061 An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease. Status COMPLETED Phase PHASE3
NCT01580020 Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO Status COMPLETED Phase PHASE4
NCT01579929 Combination of the Hedgehog Inhibitor, LDE225, With Etoposide and Cisplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) Status COMPLETED Phase PHASE1
NCT01578928 A Phase l Study to Evaluate the Pharmacokinetics and Safety Pasireotide in Subjects With Varying Degrees of Renal Impairment Compared to Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01578330 A 12 -Month, Open-label, Multi-center Study to Explore the Health Outcomes of FTY720 Status COMPLETED Phase PHASE4
NCT01576666 Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01576380 A Phase II Study to Evaluate Efficacy and Safety of Dovitinib (TKI258) in Advanced Scirrhous Gastric Carcinoma Patients Status COMPLETED Phase PHASE2
NCT01576367 Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease Status COMPLETED Phase PHASE3
NCT01574651 The Effect of QVA149 on Health Related Quality of Life in Patients With Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE3